Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients.
Gelibter A, Tuosto L, Asquino A, Siringo M, Sabatini A, Zizzari IG, Pace A, Scirocchi F, Valentino F, Bianchini S, Caponnetto S, Paoli D, Bellati F, Santini D, Nuti M, Rughetti A, Napoletano C. Gelibter A, et al. Among authors: caponnetto s. Front Immunol. 2024 Dec 18;15:1483182. doi: 10.3389/fimmu.2024.1483182. eCollection 2024. Front Immunol. 2024. PMID: 39744631 Free PMC article.
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer.
Nicolazzo C, Magri V, Marino L, Belardinilli F, Di Nicolantonio F, De Renzi G, Caponnetto S, De Meo M, Giannini G, Santini D, Cortesi E, Gazzaniga P. Nicolazzo C, et al. Among authors: caponnetto s. Front Oncol. 2023 Mar 29;13:1160673. doi: 10.3389/fonc.2023.1160673. eCollection 2023. Front Oncol. 2023. PMID: 37064137 Free PMC article.
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management.
Roberto M, Panebianco M, Aschelter AM, Buccilli D, Cantisani C, Caponnetto S, Cortesi E, d'Amuri S, Fofi C, Ierinò D, Maestrini V, Marchetti P, Marignani M, Stigliano A, Vivona L, Santini D, Tomao S. Roberto M, et al. Among authors: caponnetto s. Front Oncol. 2023 Jan 12;12:1026978. doi: 10.3389/fonc.2022.1026978. eCollection 2022. Front Oncol. 2023. PMID: 36713496 Free PMC article. Review.
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review.
Sidrak MMA, De Feo MS, Frantellizzi V, Marongiu A, Caponnetto S, Filippi L, Nuvoli S, Spanu A, Schillaci O, De Vincentis G. Sidrak MMA, et al. Among authors: caponnetto s. Cancer Biother Radiopharm. 2023 May;38(4):232-245. doi: 10.1089/cbr.2022.0049. Epub 2023 Jan 9. Cancer Biother Radiopharm. 2023. PMID: 36622960
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study.
Bauckneht M, Rebuzzi SE, Ponzano M, Borea R, Signori A, Frantellizzi V, Lodi Rizzini E, Mascia M, Lavelli V, Miceli A, De Feo MS, Pisani AR, Nuvoli S, Tripoli V, Morganti AG, Mammucci P, Caponnetto S, Mantica G, Di Nicola AD, Villano C, Cindolo L, Morbelli S, Sambuceti G, Fanti S, Costa RP, Spanu A, Rubini G, Monari F, De Vincentis G, Fornarini G. Bauckneht M, et al. Among authors: caponnetto s. Cancers (Basel). 2022 Mar 29;14(7):1744. doi: 10.3390/cancers14071744. Cancers (Basel). 2022. PMID: 35406515 Free PMC article.
180 results